Filing Details
- Accession Number:
- 0001209191-13-007676
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-11 15:59:34
- Reporting Period:
- 2013-02-08
- Filing Date:
- 2013-02-11
- Accepted Time:
- 2013-02-11 15:59:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 59478 | Lilly Eli & Co | LLY | Pharmaceutical Preparations (2834) | 350470950 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1538604 | A David Ricks | Lilly Corporate Center Indianapolis IN 46285 | Svp And Pres, Lilly Bio-Meds | No | Yes | No | No |
Transaction Summary
| Sold: | 3,000 shares | Avg. Price: $53.91 | Total Value: $161,730.00 |
| Number of Shares After Transactions: | 26,941 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-02-08 | 3,000 | $53.91 | 26,941 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,318 | Indirect | 401(k) |
Billionaire Hedge Funds
